The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

被引：0
|
作者：
Christoforos Hadjichrysanthou
Stephanie Evans
Sumali Bajaj
Loizos C. Siakallis
Kevin McRae-McKee
Frank de Wolf
Roy M. Anderson
机构：
[1] Imperial College London,Department of Infectious Disease Epidemiology, School of Public Health
[2] Public Health England,Modelling and Economics Unit, National Infection Service
[3] University College London Hospitals,Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery
来源：
Alzheimer's Research & Therapy | / 12卷
关键词：
Alzheimer’s disease; Dementia; Biomarker trajectories; Clinical states; Time to event; Markov chain; ADNI; CSF; PET; Plasma; Brain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues
    Leuzy, Antoine
    Zimmer, Eduardo Rigon
    Heurling, Kerstin
    Rosa-Neto, Pedro
    Gauthier, Serge
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2014, 21 (03): : 143 - 148
  • [42] Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome
    Zis, Panagiotis
    Strydom, Andre
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 114 : 3 - 9
  • [43] Blood biomarkers for Alzheimer’s disease in clinical practice and trials
    Oskar Hansson
    Kaj Blennow
    Henrik Zetterberg
    Jeffrey Dage
    Nature Aging, 2023, 3 : 506 - 519
  • [44] Clinical use of biomarkers in the era of Alzheimer's disease treatments
    Vandevrede, Lawren
    Schindler, Suzanne E.
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [45] Clinical significance of plasma candidate biomarkers of Alzheimer's Disease
    Lewczuk, Piotr
    Lukaszewicz-Zajac, Marta
    Kornhuber, Johannes
    Mroczko, Barbara
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (04) : 363 - 379
  • [46] Alzheimer's Disease and the Routine Clinical Use of CSF Biomarkers
    Martorana, Alessandro
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 407 - 413
  • [47] Biomarkers for the Early Stages of Clinical Development in Alzheimer's Disease
    Bordet, Regis
    Dartigues, Jean-Francois
    Dubois, Bruno
    Goehrs, Jean-Marie
    Vernoux, Laura
    Semah, Franck
    Pasquier, Florence
    Bidaut-Mazel, Claude
    THERAPIE, 2010, 65 (04): : 285 - 290
  • [48] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [49] Alzheimer's disease biomarkers: Their value in diagnosis and clinical trials
    Small, DH
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D986 - D988
  • [50] The potential clinical value of plasma biomarkers in Alzheimer's disease
    Blennow, Kaj
    Galasko, Douglas
    Perneczky, Robert
    Quevenco, Frances-Catherine
    van der Flier, Wiesje M.
    Akinwonmi, Akin
    Carboni, Margherita
    Jethwa, Alexander
    Suridjan, Ivonne
    Zetterberg, Henrik
    ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5805 - 5816
12345